Several clinical studies reported the significance of EIF3C in predicting patients' prognosis in various human cancers, such as intrahepatic cholangiocarcinoma, prostate cancer, and endometrial cancer [21, 39, 40]. This evidence concerns the gene EIF3C and prostate carcinoma.